- Home
- CTNM vs MGRM Comparison
CTNM vs MGRM Comparison
Compare CTNM & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- MGRM
- Stock Information
- Founded
- CTNM 2009
- MGRM 2016
- Country
- CTNM United States
- MGRM United States
- Employees
- CTNM N/A
- MGRM N/A
- Industry
- CTNM
- MGRM Medical/Dental Instruments
- Sector
- CTNM
- MGRM Health Care
- Exchange
- CTNM Nasdaq
- MGRM Nasdaq
- Market Cap
- CTNM 174.6M
- MGRM 195.3M
- IPO Year
- CTNM 2024
- MGRM N/A
- Fundamental
- Price
- CTNM $7.38
- MGRM $5.33
- Analyst Decision
- CTNM Strong Buy
- MGRM Strong Buy
- Analyst Count
- CTNM 4
- MGRM 1
- Target Price
- CTNM $22.50
- MGRM $5.40
- AVG Volume (30 Days)
- CTNM 196.1K
- MGRM 199.9K
- Earning Date
- CTNM 08-05-2025
- MGRM 08-26-2025
- Dividend Yield
- CTNM N/A
- MGRM N/A
- EPS Growth
- CTNM N/A
- MGRM N/A
- EPS
- CTNM N/A
- MGRM N/A
- Revenue
- CTNM N/A
- MGRM N/A
- Revenue This Year
- CTNM N/A
- MGRM N/A
- Revenue Next Year
- CTNM N/A
- MGRM N/A
- P/E Ratio
- CTNM N/A
- MGRM N/A
- Revenue Growth
- CTNM N/A
- MGRM N/A
- 52 Week Low
- CTNM $3.35
- MGRM $1.92
- 52 Week High
- CTNM $20.55
- MGRM $6.02
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- MGRM 62.45
- Support Level
- CTNM N/A
- MGRM $5.29
- Resistance Level
- CTNM N/A
- MGRM $5.42
- Average True Range (ATR)
- CTNM 0.00
- MGRM 0.12
- MACD
- CTNM 0.00
- MGRM -0.12
- Stochastic Oscillator
- CTNM 0.00
- MGRM 21.28
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.